Morphine

Generic Name
Morphine
Brand Names
Arymo, Avinza, Doloral, Duramorph, Embeda, Infumorph, Kadian, M-ediat, M-eslon, MSIR, Mitigo, Ms Contin, Statex
Drug Type
Small Molecule
Chemical Formula
C17H19NO3
CAS Number
57-27-2
Unique Ingredient Identifier
76I7G6D29C
Background

Morphine, the main alkaloid of opium, was first obtained from poppy seeds in 1805. It is a potent analgesic, though its use is limited due to tolerance, withdrawal, and the risk of abuse. Morphine is still routinely used today, though there are a number of semi-synthetic opioids of varying strength such as codeine, fentanyl, methadone, hydrocodone, hydromorphone, meperidine, and oxycodone.

Morphine was granted FDA approval in 1941.

Indication

Morphine is used for the management of chronic, moderate to severe pain.

Opiods, including morphine, are effective for the short term management of pain. Patients taking opioids long term may need to be monitored for the development of physical dependence, addiction disorder, and drug abuse.

Associated Conditions
Chronic Pain, Severe Pain
Associated Therapies
-

Influence of Morphine on Pharmacokinetics and Pharmacodynamics of Ticagrelor in Patients With Acute Myocardial Infarction

First Posted Date
2014-08-15
Last Posted Date
2017-09-12
Lead Sponsor
Collegium Medicum w Bydgoszczy
Target Recruit Count
74
Registration Number
NCT02217878
Locations
🇵🇱

Cardiology Department, Dr. A. Jurasz University Hospital, Bydgoszcz, Kujawsko-pomorskie, Poland

Dexmedetomidine for Postoperative Analgesia After Bariatric Surgery

First Posted Date
2014-08-11
Last Posted Date
2016-07-13
Lead Sponsor
American University of Beirut Medical Center
Target Recruit Count
60
Registration Number
NCT02213159
Locations
🇱🇧

American University of Beirut Medical Center, Beirut, Lebanon

Comparison of MEOPA + Paracetamol Versus Morphine Treatment in Acute Coronary Syndrome Analgesia.

First Posted Date
2014-07-23
Last Posted Date
2018-02-05
Lead Sponsor
University Hospital, Toulouse
Target Recruit Count
680
Registration Number
NCT02198378
Locations
🇫🇷

Centre Hospitalier Louis Pasteur, Chartres, France

🇫🇷

Centre Hospitalier Dijon, Dijon, France

🇫🇷

Centre Hospitalier Jean Minjoz, Besançon, France

and more 37 locations

Efficacy Study of Different Analgesic Options in Kidney Stone Pain Management

First Posted Date
2014-07-11
Last Posted Date
2015-03-18
Lead Sponsor
Hamad Medical Corporation
Target Recruit Count
1645
Registration Number
NCT02187614
Locations
🇶🇦

Emergency Department, Hamad General Hospital., Doha, Qatar

Acupuncture Versus IV Morphine in the Treatment of Acute Pain in ED

Early Phase 1
Completed
Conditions
Interventions
First Posted Date
2014-06-02
Last Posted Date
2016-06-20
Lead Sponsor
University of Monastir
Target Recruit Count
100
Registration Number
NCT02152410
Locations
🇹🇳

university of Monastir, Monastir, Non-US/Canada, Tunisia

🇹🇳

Fattouma Bourguiba University Hospital, Monastir, Tunisia

Post Operative Pain Control: Morphine vs Fentanyl

Not Applicable
Completed
Conditions
Interventions
First Posted Date
2014-05-26
Last Posted Date
2014-05-26
Lead Sponsor
Catholic University of the Sacred Heart
Target Recruit Count
60
Registration Number
NCT02146638
Locations
🇮🇹

catholic University of the sacred Heart, Rome, Italy

Efficacy of Fentanyl to Reduce the Time of Severe Postoperative Pain Relief Compared to Morphine

Phase 3
Completed
Conditions
Interventions
First Posted Date
2014-05-23
Last Posted Date
2014-05-23
Lead Sponsor
Universidad de Antioquia
Target Recruit Count
60
Registration Number
NCT02145975
Locations
🇨🇴

Antioquia University, Medellin, Antioquia, Colombia

Low Pain Prediction in Cesarean Section Patients

First Posted Date
2014-05-20
Last Posted Date
2018-09-10
Lead Sponsor
Wake Forest University Health Sciences
Target Recruit Count
13
Registration Number
NCT02143141
Locations
🇺🇸

Forsyth Medical Center, Winston-Salem, North Carolina, United States

Analgesic Response to Opioid Analgesics in Buprenorphine-Maintained Individuals

First Posted Date
2014-05-13
Last Posted Date
2014-05-13
Lead Sponsor
University of California, Los Angeles
Target Recruit Count
12
Registration Number
NCT02136784
Locations
🇺🇸

UCLA Integrated Substance Abuse Programs Outpatient Clinical Research Center, Los Angeles, California, United States

© Copyright 2024. All Rights Reserved by MedPath